Obmed Pharma Private Limited
About Obmed Pharma Private Limited
Data last updated:
Obmed Pharma Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 18 July 2022.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24290MH2022PTC386951.
The company has an authorised share capital of ₹15 Lakh and a paid-up capital of ₹15 Lakh. It is led by directors Raj Shekhar and Varun Shrivastava.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Unit No. 1104 11th Floor Kailas Corporate Lounge, Veer Savarkar Marg Vikhroli West Mumbai, Maharashtra, India – 400079.
As per the financials filed for FY 2025, the company reported a revenue of ₹14.34 Lakh. For the same year it recorded a net loss of ₹90.05 Lakh and EBITDA of -₹86.02 Lakh.
Court records list 1 case involving the company, including 1 filed against it.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Obmed Pharma Private Limited's registered office is in Mumbai, Maharashtra.
- Registered AddressUnit No. 1104 11th Floor Kailas Corporate Lounge, Veer Savarkar Marg Vikhroli West Mumbai, Maharashtra, India – 400079
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Obmed Pharma Private Limited
FY 2025 filings availableObmed Pharma Private Limited reported revenue of ₹14.34 Lakh for FY 2025.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | |||
| Other Income | |||
| Total Revenue | |||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | -₹86.02 Lakh | ||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | -₹90.05 Lakh | ||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | |||
| Net Profit Margin | |||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Obmed Pharma Private Limited, buy the company report.
Board of directors of Obmed Pharma Private Limited
Obmed Pharma has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Raj Shekhar | Director | 18 Jul 2022 | 4 Years 3 Months | Current |
| Varun Shrivastava | Director | 02 Sep 2023 | 3 Years 1 Months | Current |
Peer comparison
Obmed Pharma Private Limited is compared with the 10 companies closest to it by revenue in the Pharma industry (Formulations), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Linum Life Science Private Limited | ₹14.58 Lakh (FY 2021) | 38.0% | Cuttack, Odisha, India | |||
| Valter Process Innovations Private Limited | ₹14.57 Lakh (FY 2024) | Bangalore, Karnataka, India | ||||
| Medmidas Healthcare Private Limited | ₹14.44 Lakh (FY 2025) | -42.0% | New Delhi, Delhi, India | |||
| Hreemcare Pharmaceutical Private Limited | ₹14.43 Lakh (FY 2025) | 57614.0% | Bardez, Goa, India | |||
| Herbo Biocare (India) Private Limited | ₹14.34 Lakh (FY 2025) | 25.0% | New Delhi, Delhi, India | |||
| Obmed Pharma Private Limitedthis company | ₹14.34 Lakh (FY 2025) | -₹90.05 Lakh | Mumbai, Maharashtra, India | |||
| Nyg Pharmaceuticals Private Limited | ₹14.34 Lakh (FY 2025) | -1.0% | New Delhi, Delhi, India | |||
| Innovation Organics India Private Limited | ₹14.31 Lakh (FY 2025) | -27.0% | Kanpur, Uttar Pradesh, India | |||
| Scania Biotech Private Limited | ₹14.3 Lakh (FY 2025) | -55.0% | Odisha, India | |||
| Optimus Medtech Private Limited | ₹14.28 Lakh (FY 2025) | 6175.0% | Pune, Maharashtra, India | |||
| Medistra Remedies Private Limited | ₹14.28 Lakh (FY 2025) | 30.0% | Bhopal, Madhya Pradesh, India |
To see the full peer comparison of Obmed Pharma Private Limited, buy the company report.
Legal cases
Obmed Pharma Private Limited has 1 court case on record: 1 filed against it. All case is disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 1 | 1 | 0 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, New Delhi, Delhi | Cheque dishonour complaint | Filed against the company by Times Internet Limited | Disposed |
To see the full case history of Obmed Pharma Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Obmed Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Obmed Pharma Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Obmed Pharma Private Limited has 3 board changes on record since 2022: 2 appointments and 1 cessation. The latest: Raj Kumar Ahuja ceased to be Director on 06 Nov 2023.
Frequently asked questions
Obmed Pharma is an active private limited company based in Mumbai, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 18 July 2022 (4+ years old) and is registered under CIN U24290MH2022PTC386951.
Obmed Pharma has 2 current directors:
- Raj Shekhar - Director
- Varun Shrivastava - Director
The latest financial statements of Obmed Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2023 are in the company report.
The CIN (Corporate Identification Number) of Obmed Pharma is U24290MH2022PTC386951. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Obmed Pharma has 1 court case on record: 1 filed against it.
Obmed Pharma was incorporated on 18 July 2022, making it 4+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Obmed Pharma by revenue are Linum Life Science Private Limited, Valter Process Innovations Private Limited, Medmidas Healthcare Private Limited, Hreemcare Pharmaceutical Private Limited, Herbo Biocare (India) Private Limited and 5 more, all in the Pharma industry (Formulations).
Raj Kumar Ahuja ceased to be Director on 06 Nov 2023. Varun Shrivastava was appointed as Director on 02 Sep 2023. Raj Shekhar was appointed as Director on 18 Jul 2022.
The registered office of Obmed Pharma is at Unit No. 1104 11th Floor Kailas Corporate Lounge, Veer Savarkar Marg Vikhroli West Mumbai, Maharashtra, India – 400079.
Obmed Pharma operates in the pharma industry, in the drug formulation and development segment.
The compliance status of Obmed Pharma is compliant as of 28 August 2026. The company is actively filing with the Registrar of Companies.